# V52 Queue: Therapeutic-Path Synthesis

Status: in-progress

V52 uses the active-time block machine, but its first value-complete target is a
therapeutic-path synthesis that combines V37 findings, restored OpenGWAS access,
and V51 structural context without reopening broad public-data discovery.

## Timing

- Block start UTC: 2026-07-10T09:43:31Z
- Active target: 6h cumulative active time
- Active session intervals:
  - 2026-07-10T09:43:31Z - open
- Wall-clock span start UTC: 2026-07-10T09:43:31Z

## Environment And Remote

- `origin`: https://github.com/sleibach/multiple-sclerosis-auto-research.git
- Local HEAD at start: `f9bbebcd25926ab8438dfe1d3fa5ecc108048183`
- `origin/main` at start: `f9bbebcd25926ab8438dfe1d3fa5ecc108048183`
- OpenGWAS token: renewed and active; POST-only checker returned HTTP 200 on
  `gwasinfo` and `tophits`; decoded expiry `2026-07-24 08:00 UTC`.
- SAP_AI_CORE_API_KEY: present; Claude/Gemini/RPT health check PASS.
- AlphaFold DB client and structural gate: to be verified in iteration guard.

## Backlog

| item | status | note |
|---|---|---|
| Write therapeutic-path synthesis report | done | `docs/reports/THERAPEUTIC_PATH_V52.md`; headline: monitoring/stratification is the honest near-term impact; no target is intervention-grade. |
| Structure-informed chr1 review: GPR25 | done | V51 AlphaFold record plus V17/V19 direction/druggability confirms structurally plausible but causally unresolved and chemically immature. |
| Structure-informed chr1 review: KIF21B | done | Retrieved AlphaFold DB `AF-O75037-F1` v6; motor-domain context is structurally interpretable but restoration/up-function direction keeps target closed. |
| Restored-OpenGWAS catch-up inventory | done | `docs/workups/genetics/RESTORED_OPENGWAS_CATCHUP_V52.md`; token active; bounded confirmed-locus rerun only. |
| Restored-OpenGWAS smoke rerun for genetics scripts | done | `scripts/v14_susie_coloc_confirmed_loci.py` reran POST-only `/ld/matrix` routes; no target verdict changed. |
| Therapeutic contradiction/convergence check | done | `knowledge_external/synthesis/V52_THERAPEUTIC_CONVERGENCE_CONTRADICTION.md`; 10 therapeutic rows reviewed, 6 convergences/context corroborations, 4 context/orthogonal rows, 0 genuine contradictions, 0 therapeutic verdict changes. |
| Validation-readiness tie-in | done | `docs/validation/THERAPEUTIC_VALIDATION_HANDOFF_V52.md`; clarifies what Gafson/Karolinska pass, immune-tone-bounded pass, fail, inconclusive, or unscoreable package means for clinical action. |
| Guard and push iteration | done | V47 provenance, V51 structural, external index, SAP health, status freshness, size/tmp guards passed; commit `f396b814` pushed to `origin/main` at 2026-07-10T09:56:54Z. |
| Structure-informed PTGER4 triage | done | AlphaFold DB `AF-P35408-F1` v6 retrieved; receptor-core structural context is compatible with tractability, but closure is confirmed because the blocker is mixed signal and direction, not lack of structure. |
| Restored-OpenGWAS ZMIZ1 bounded direction handoff | done | `docs/workups/genetics/ZMIZ1_RESTORED_OPENGWAS_HANDOFF_V52.md`; restored token can polish bounded direction manifests but does not create a ZMIZ1 target route. |
| Public-facing therapeutic summary card | done | `docs/reports/THERAPEUTIC_PATH_SUMMARY_CARD_V52.md`; compact medical-team handoff: validate monitoring first, no target intervention-grade, exact next data asks. |
| Chr1 genotype-linked data specification | done | `docs/workups/genetics/CHR1_GENOTYPE_LINKED_DATA_SPEC_V52.md`; exact future data package needed to resolve GPR25 vs KIF21B and direction/modality. |
| V52 therapeutic validation handoff | done | `docs/validation/THERAPEUTIC_VALIDATION_HANDOFF_V52.md`; converts monitoring-first conclusion into validation-ready medical-team action items. |
| PTGER4 signal-specific reopen spec | done | `docs/workups/genetics/PTGER4_SIGNAL_SPECIFIC_REOPEN_SPEC_V52.md`; reopen requires one disease-relevant signal, one causal direction, one relevant cell state, and one plausible modality. |
| GPR25 direction-matched modality spec | done | `docs/workups/genetics/GPR25_DIRECTION_MATCHED_MODALITY_SPEC_V52.md`; requires causal-gene resolution, cell-state presence, protective higher/restored direction, functional readout, and agonism/restoration modality. |
| KIF21B restoration modality spec | done | `docs/workups/genetics/KIF21B_RESTORATION_MODALITY_SPEC_V52.md`; standard inhibition/degradation/knockdown remain wrong-direction unless future data prove otherwise. |
| Machine-readable therapeutic target matrix | done | `docs/reports/THERAPEUTIC_TARGET_EVIDENCE_MATRIX_V52.tsv`; 13 route/lead rows encode impact path, blocker, reopen evidence, next action, and verdict. |
| Medical-team therapeutic request packet | done | `docs/validation/MEDICAL_TEAM_THERAPEUTIC_DATA_REQUEST_V52.md`; separates monitoring validation, chr1 target-development, postpartum, and T/B data asks. |
| Structure evidence boundary QA | done | `docs/reports/STRUCTURAL_EVIDENCE_BOUNDARY_QA_V52.md`; tightened over-strong "confirms" wording and kept AlphaFold as context only. |
| Restored-genetics bounded rerun manifest | done | `docs/workups/genetics/RESTORED_OPENGWAS_BOUNDED_RERUN_MANIFEST_V52.md`; records completed bounded reruns, allowed polish, and excluded discovery. |
| Therapeutic contradiction surveillance triggers | done | `docs/reports/THERAPEUTIC_CONTRADICTION_SURVEILLANCE_V52.md`; defines same-level contradiction triggers, non-triggers, and queueing rule. |
| Monitoring validation decision tree | done | `docs/validation/MONITORING_VALIDATION_DECISION_TREE_V52.md`; mechanical if/then tree for package eligibility, scoring, outcome class, and next action. |
| V52 therapeutic artifact index | done | `docs/reports/THERAPEUTIC_PATH_INDEX_V52.md`; navigation by executive synthesis, validation, genetics/target handoff, structural context, and surveillance. |
| chr1 direction-matched experiment blueprint | done | `docs/workups/genetics/CHR1_DIRECTION_MATCHED_EXPERIMENT_BLUEPRINT_V52.md`; staged flow from package intake through causal gene, direction, perturbation, modality, and final class. |
| Therapeutic reopen checklist TSV | done | `docs/reports/THERAPEUTIC_REOPEN_CHECKLIST_V52.tsv`; machine-readable reopen gates and non-counting evidence for closed/conditional leads. |
| External-skeptic therapeutic rebuttal checklist | done | `docs/reports/THERAPEUTIC_SKEPTIC_REBUTTAL_CHECKLIST_V52.md`; pre-answers monitoring-first, no-target, structure, OpenGWAS, confounder, and power objections. |
| V52 artifact consistency audit | done | `docs/reports/THERAPEUTIC_ARTIFACT_CONSISTENCY_AUDIT_V52.md`; no inconsistency found across V52 therapeutic report, summary, matrices, request packet, and validation handoffs. |
| Monitoring validation command manifest | done | `docs/validation/MONITORING_VALIDATION_COMMAND_MANIFEST_V52.md`; exact interpreter precheck, preflight gates, frozen harness command, outputs, and non-commands. |
| Therapeutic claim hierarchy | done | `docs/reports/THERAPEUTIC_CLAIM_HIERARCHY_V52.md`; separates locked rules, grounded findings, provisional monitoring, mechanism context, target handoffs, structure context, and future asks. |
| Target package acceptance criteria TSV | done | `docs/validation/TARGET_PACKAGE_ACCEPTANCE_CRITERIA_V52.tsv`; machine-readable accept/partial/reject criteria by package type. |
| Prospective monitoring utility study sketch | done | `docs/validation/PROSPECTIVE_MONITORING_UTILITY_STUDY_SKETCH_V52.md`; defines the post-validation prospective utility study needed before any score-guided clinical action. |
| Monitoring-to-clinical-utility boundary checklist | done | `docs/validation/MONITORING_CLINICAL_UTILITY_BOUNDARY_CHECKLIST_V52.md`; separates scoreability, external validation, pharmacodynamic monitoring, clinical utility, and treatment-action evidence. |
| Chr1 collaborator assay request appendix | done | `docs/workups/genetics/CHR1_COLLABORATOR_ASSAY_REQUEST_APPENDIX_V52.md`; translates chr1 direction-matched requirements into concrete genotype, cell-state, protein, perturbation, and metadata asks. |
| V52 machine-readable artifact manifest | done | `docs/reports/THERAPEUTIC_ARTIFACT_MANIFEST_V52.tsv`; enumerates V52 artifact path, category, status, evidence role, primary use, and notes for downstream tooling. |
| Therapeutic route risk register | done | `docs/reports/THERAPEUTIC_ROUTE_RISK_REGISTER_V52.md`; catalogs residual route-level and cross-cutting risks, mitigations, and escalation triggers without changing verdicts. |
| Therapeutic route assumption ledger | done | `docs/reports/THERAPEUTIC_ROUTE_ASSUMPTION_LEDGER_V52.md`; makes explicit the assumptions behind monitoring-first, chr1 handoff, and no-current-target conclusions and how future data could revise them. |
| Incoming-package communication templates | done | `docs/validation/INCOMING_PACKAGE_COMMUNICATION_TEMPLATES_V52.md`; gives accept, partial-context, reject/unscoreable, access-term-blocked, and missing-field response templates. |
| Monitoring validation result report template | done | `docs/validation/MONITORING_VALIDATION_RESULT_REPORT_TEMPLATE_V52.md`; fixed shell for future Gafson/Karolinska preflight, primary metrics, confounder/batch results, final class, and next action. |
| chr1 package result report template | done | `docs/workups/genetics/CHR1_PACKAGE_RESULT_REPORT_TEMPLATE_V52.md`; fixed shell for future chr1 intake, causal-gene, direction, cell-state, perturbation, modality, and final decision classes. |
| V52 package checksum intake checklist | done | `docs/validation/PACKAGE_CHECKSUM_INTAKE_CHECKLIST_V52.md`; concise access-terms, quarantine, checksum, package-type, no-raw-git, and stop/go checklist for incoming packages. |
| Therapeutic route decision log template | done | `docs/reports/THERAPEUTIC_ROUTE_DECISION_LOG_TEMPLATE_V52.md`; fixed future route-status change template requiring counted evidence, gate results, and explicit non-counting context. |
| V52 route-status dashboard table | done | `docs/reports/THERAPEUTIC_ROUTE_STATUS_DASHBOARD_V52.tsv`; compact machine-readable route status, next gate, blocker, action, and verdict dashboard. |
| Monitoring operator one-page run card | done | `docs/validation/MONITORING_OPERATOR_ONE_PAGE_CARD_V52.md`; one-page monitoring package receipt-to-result class card for operators. |
| chr1 operator one-page run card | done | `docs/workups/genetics/CHR1_OPERATOR_ONE_PAGE_CARD_V52.md`; one-page chr1 genotype-linked package receipt-to-final-staged-class card. |
| V52 artifact cross-link audit | done | `docs/reports/V52_ARTIFACT_CROSS_LINK_AUDIT.md`; checked key V52 artifacts across manifest, index, summary, current status, next actions, and queue; no unexpected missing links. |
| OpenGWAS pre-expiry bounded-polish command list | done | `docs/workups/genetics/OPENGWAS_PRE_EXPIRY_BOUNDED_POLISH_COMMANDS_V52.md`; exact bounded POST-only commands before 2026-07-24, with broad discovery excluded. |
| Bounded OpenGWAS script existence audit | done | Folded into `docs/workups/genetics/OPENGWAS_PRE_EXPIRY_BOUNDED_POLISH_COMMANDS_V52.md`; V14/V19 are preferred bounded commands; V13/V21 scripts are not pre-approved for V52 polish. |
| V52 RAG/index refresh | done | `.venv_v3_py312/bin/python scripts/build_knowledge_index.py`; refreshed `knowledge/.index/` over 783 documents and smoke-query returned V52 therapeutic artifacts. |
| Validation package field dictionary | done | `docs/validation/VALIDATION_PACKAGE_FIELD_DICTIONARY_V52.tsv`; machine-readable required and optional fields by package type. |
| Therapeutic path reviewer quickstart | done | `docs/reports/THERAPEUTIC_REVIEWER_QUICKSTART_V52.md`; reader roles, challenge map, and claim-boundary reminders. |
| Monitoring pass/fail public wording table | done | `docs/validation/MONITORING_PUBLIC_WORDING_TABLE_V52.tsv`; safe public wording, caveat, forbidden wording, and next action by monitoring result class. |
| chr1 no-go communication appendix | done | `docs/workups/genetics/CHR1_NO_GO_COMMUNICATION_APPENDIX_V52.md`; collaborator-safe wording for real chr1 biology without target promotion. |
| V52 artifact hash snapshot | done | `docs/reports/V52_OPERATOR_ARTIFACT_HASH_SNAPSHOT.tsv`; SHA256 snapshot of key operator artifacts, excluding mutable navigation docs. |
| Monitoring result-class examples | done | `docs/validation/MONITORING_RESULT_CLASS_EXAMPLES_V52.md`; concrete scenario-to-class examples for future monitoring packages. |
| chr1 wrong-direction control checklist | done | `docs/workups/genetics/CHR1_WRONG_DIRECTION_CONTROL_CHECKLIST_V52.md`; labels and interpretation rules for wrong-direction perturbation controls. |
| Post-validation route update playbook | done | `docs/reports/POST_VALIDATION_ROUTE_UPDATE_PLAYBOOK_V52.md`; future route-status transition rules for monitoring and chr1 package outcomes. |
| Therapeutic no-target public abstract | done | `docs/reports/THERAPEUTIC_NO_TARGET_PUBLIC_ABSTRACT_V52.md`; public abstract states monitoring-ready and no current target without overclaiming. |
| OpenGWAS expiry-day runbook | done | `meta/OPENGWAS_EXPIRY_DAY_RUNBOOK_V52.md`; expiry-day and renewal routing, with auth failures classified as operational blockers. |
| V52 artifact hash verification command note | done | `docs/reports/V52_OPERATOR_ARTIFACT_HASH_VERIFY_COMMANDS.md`; compact command note for checking the operator artifact hash snapshot against current files. |
| Validation package route classifier table | done | `docs/validation/VALIDATION_PACKAGE_ROUTE_CLASSIFIER_V52.tsv`; machine-readable route classifier mapping incoming package metadata to monitoring, chr1, secondary biology, context-only, or reject. |
| Validation route classifier worked examples | done | `docs/validation/VALIDATION_PACKAGE_ROUTE_CLASSIFIER_EXAMPLES_V52.tsv`; plausible incoming packages mapped to route classes without running analysis. |
| Incoming package preflight checklist consolidation | todo | Produce a one-page preflight that orders checksum, terms, route classification, field dictionary, and acceptance criteria. |
| Chr1 target-resolution decision compact | todo | Create a compact go/no-go table for chr1 packages after classifier routing. |
| Monitoring package minimum viable package checklist | todo | Create a concise required-vs-nice-to-have checklist for paired PBMC response packages. |
| Therapeutic package handoff bundle index | todo | Bundle the operator-facing validation, chr1, and hash artifacts into a sendable handoff index. |
| V52 route classifier TSV validation command | todo | Add a compact TSV schema check command for the classifier table. |
| Final V52 active-time/run summary update | todo | Close session interval only when stopping at a valid boundary; report active and wall-clock time separately. |
| Structure-aware no-go table | done | `docs/workups/genetics/STRUCTURE_AWARE_NO_GO_TABLE_V52.md`; structure sharpens feasibility but cannot override causal-gene, direction, cell-state, or modality blockers. |
| OpenGWAS renewal watch note | done | `meta/OPENGWAS_RENEWAL_WATCH_V52.md`; token verified active on 2026-07-10 and expires 2026-07-24 08:00 UTC; auth failures are operational blockers, not null results. |

## Per-Iteration Notes

- 2026-07-10T09:43:31Z: V52 started. OpenGWAS `.env` override uses renewed JWT;
  POST-only checker passed (`gwasinfo`, `tophits`) with expiry
  `2026-07-24 08:00 UTC`. Remote aligned at `f9bbebcd`. SAP AI Core health
  check passed for Claude/Gemini/RPT.
- 2026-07-10T09:50:02Z: Wrote `docs/reports/THERAPEUTIC_PATH_V52.md`, added
  KIF21B AlphaFold DB structural record (`O75037`) and context note, reran
  V19 chr1 local reanalysis and V14 confirmed-locus SuSiE-coloc with restored
  OpenGWAS POST-only access. Therapeutic headline: monitoring/stratification is
  the strongest near-term impact; chr1 remains real biology but not
  intervention-grade.
- 2026-07-10T09:55:38Z: Guard checkpoint passed: provenance gate, structural
  synthetic fixtures, structural record audit, external Markdown/index linters,
  SAP AI Core health, V52-aware status freshness, tracked-file size guard, and
  tracked-`tmp/` guard. Preparing first V52 commit and push.
- 2026-07-10T09:56:54Z: First V52 iteration committed and pushed as
  `f396b814`; local and `origin/main` match. Continuing with therapeutic
  convergence/contradiction content rather than stopping below the 6h active
  target.
- 2026-07-10T09:59:16Z: Wrote and indexed
  `knowledge_external/synthesis/V52_THERAPEUTIC_CONVERGENCE_CONTRADICTION.md`.
  Result: no genuine therapeutic contradiction surfaced; external context
  supports validation guardrails and cautionary target closures but does not
  validate the scalar or create an intervention-grade target.
- 2026-07-10T10:01:18Z: Therapeutic convergence check committed and pushed as
  `f1573e33`; local and `origin/main` match. Continuing with validation-
  readiness tie-in.
- 2026-07-10T10:02:53Z: Wrote
  `docs/validation/THERAPEUTIC_VALIDATION_HANDOFF_V52.md` and linked it from
  the therapeutic report, validation-readiness doc, current status, and next
  actions. It keeps V42/V44 frozen and translates outcomes into medical-team
  actionability.
- 2026-07-10T10:04:01Z: Validation handoff committed and pushed as
  `91f1b780`; local and `origin/main` match. Continuing with PTGER4
  structure-informed triage.
- 2026-07-10T10:06:23Z: Retrieved PTGER4 AlphaFold DB `AF-P35408-F1` v6
  (`P35408`) and wrote
  `knowledge_external/synthesis/V52_PTGER4_ALPHAFOLD_DRUGGABILITY_CONTEXT.md`.
  Result: PTGER4 remains closed as a naive transfer target; structure sharpens
  receptor-core context but does not address mixed-signal/direction blockers.
- 2026-07-10T10:09:18Z: PTGER4 structural triage committed and pushed as
  `e9558a63`; local and `origin/main` match. Continuing with ZMIZ1
  restored-OpenGWAS bounded direction handoff.
- 2026-07-10T10:10:51Z: Wrote
  `docs/workups/genetics/ZMIZ1_RESTORED_OPENGWAS_HANDOFF_V52.md`. Result:
  restored OpenGWAS can support bounded chr10 direction-manifest polish, but
  ZMIZ1 remains a transfer-validity warning and not a therapeutic target.
- 2026-07-10T10:12:06Z: ZMIZ1 handoff committed and pushed as `6111f67f`;
  local and `origin/main` match. Continuing with public-facing therapeutic
  summary card.
- 2026-07-10T10:13:18Z: Wrote
  `docs/reports/THERAPEUTIC_PATH_SUMMARY_CARD_V52.md`, linked from the main
  therapeutic report and live navigation. It states the public-facing V52
  bottom line: validate monitoring first; no intervention-grade target yet.
- 2026-07-10T10:14:28Z: Therapeutic summary card committed and pushed as
  `a49ea3f4`; local and `origin/main` match. Continuing with chr1
  genotype-linked data specification.
- 2026-07-10T10:16:04Z: Wrote
  `docs/workups/genetics/CHR1_GENOTYPE_LINKED_DATA_SPEC_V52.md`. Result: chr1
  target work now has an exact genotype-linked immune/CSF expression/protein
  and perturbation data ask; no target is reopened without that package.
- 2026-07-10T10:17:20Z: chr1 data specification committed and pushed as
  `addb5b2b`; local and `origin/main` match. Continuing with structure-aware
  no-go table.
- 2026-07-10T10:18:37Z: Wrote
  `docs/workups/genetics/STRUCTURE_AWARE_NO_GO_TABLE_V52.md`. Result: GPR25,
  KIF21B, PTGER4, and ZMIZ1 remain no-go for target promotion until
  direction-matched biology and modality evidence arrive; AlphaFold context does
  not override grounded genetics.
- 2026-07-10T10:20:12Z: Structure-aware no-go table committed and pushed as
  `fe27f02e`; local and `origin/main` match. Continuing with OpenGWAS renewal
  watch note.
- 2026-07-10T10:21:13Z: Wrote `meta/OPENGWAS_RENEWAL_WATCH_V52.md`.
  Result: renewed token expiry and route-around behavior are explicit for
  targeted genetics reruns.
- 2026-07-10T10:22:46Z: OpenGWAS renewal watch committed and pushed as
  `63e84fca`; local and `origin/main` match. Continuing with PTGER4
  signal-specific reopen spec.
- 2026-07-10T10:24:13Z: Wrote
  `docs/workups/genetics/PTGER4_SIGNAL_SPECIFIC_REOPEN_SPEC_V52.md`. Result:
  PTGER4 has a strict reopen gate; structure or generic GPCR tractability alone
  still does not count.
- 2026-07-10T10:26:21Z: PTGER4 reopen specification committed and pushed as
  `a31b476d`; local and `origin/main` match. Continuing with GPR25 direction-
  matched modality spec.
- 2026-07-10T10:27:46Z: Wrote
  `docs/workups/genetics/GPR25_DIRECTION_MATCHED_MODALITY_SPEC_V52.md`.
  Result: GPR25 needs a full protective-haplotype to restoration/agonism chain
  before target workup; GPCR structure or class membership alone remains
  insufficient.
- 2026-07-10T10:29:04Z: GPR25 modality specification committed and pushed as
  `e46233e4`; local and `origin/main` match. Continuing with KIF21B
  restoration modality spec.
- 2026-07-10T10:30:27Z: Wrote
  `docs/workups/genetics/KIF21B_RESTORATION_MODALITY_SPEC_V52.md`. Result:
  KIF21B requires causal resolution plus restoration/up-function modality and
  protective perturbation evidence before target workup.
- 2026-07-10T10:33:44Z: KIF21B restoration specification committed and pushed
  as `30368f2b`; local and `origin/main` match. Refilled the executable backlog
  and started the machine-readable therapeutic target evidence matrix.
- 2026-07-10T10:33:44Z: Wrote
  `docs/reports/THERAPEUTIC_TARGET_EVIDENCE_MATRIX_V52.tsv`, a 13-row
  machine-readable therapeutic route matrix. Shape check passed: every row has
  10 tab-separated fields.
- 2026-07-10T10:37:15Z: Wrote
  `docs/validation/MEDICAL_TEAM_THERAPEUTIC_DATA_REQUEST_V52.md`. Result:
  the medical-team request now separates the primary treatment-response
  validation package from the separate chr1 target-development package and
  secondary postpartum/T-B packages.
- 2026-07-10T10:39:33Z: Ran structural wording QA across V52 therapeutic docs
  and wrote `docs/reports/STRUCTURAL_EVIDENCE_BOUNDARY_QA_V52.md`. Tightened
  over-strong "confirms" wording; no target verdict changed.
- 2026-07-10T10:42:22Z: Wrote
  `docs/workups/genetics/RESTORED_OPENGWAS_BOUNDED_RERUN_MANIFEST_V52.md`.
  Result: renewed-token genetics work is bounded to completed V14/V19 reruns
  and specific future polish; broad public-data discovery remains closed.
- 2026-07-10T10:44:24Z: Wrote
  `docs/reports/THERAPEUTIC_CONTRADICTION_SURVEILLANCE_V52.md`. Result:
  future sources now have explicit same-evidence-level contradiction triggers,
  non-triggers, and a queueing rule before any V52 verdict can be revisited.
- 2026-07-10T10:47:14Z: Refilled the V52 backlog and wrote
  `docs/validation/MONITORING_VALIDATION_DECISION_TREE_V52.md`. Result: package
  receipt and outcome interpretation now have a compact if/then handoff without
  changing V42/V44 rules.
- 2026-07-10T10:49:29Z: Wrote
  `docs/reports/THERAPEUTIC_PATH_INDEX_V52.md`. Result: V52 therapeutic
  artifacts are now navigable by reader intent and operational use.
- 2026-07-10T10:53:14Z: Wrote
  `docs/workups/genetics/CHR1_DIRECTION_MATCHED_EXPERIMENT_BLUEPRINT_V52.md`.
  Result: chr1 has a staged future experiment plan that can classify packages
  as target-workup ready, biology-only, wrong-direction, incomplete, or closed.
- 2026-07-10T10:55:12Z: Wrote
  `docs/reports/THERAPEUTIC_REOPEN_CHECKLIST_V52.tsv`. Result: closed and
  conditional routes now have machine-readable reopen gates and explicit
  non-counting evidence.
- 2026-07-10T10:57:12Z: Wrote
  `docs/reports/THERAPEUTIC_SKEPTIC_REBUTTAL_CHECKLIST_V52.md`. Result: the
  strongest objections to the V52 monitoring-first/no-target conclusion now have
  artifact-backed answers and explicit residual gaps.
- 2026-07-10T10:59:51Z: Ran V52 artifact consistency scan and wrote
  `docs/reports/THERAPEUTIC_ARTIFACT_CONSISTENCY_AUDIT_V52.md`. Result:
  monitoring-first, no-current-target, chr1-handoff, structure-boundary, and
  bounded-OpenGWAS messages are consistent across checked artifacts.
- 2026-07-10T11:01:57Z: Refilled the V52 backlog and wrote
  `docs/validation/MONITORING_VALIDATION_COMMAND_MANIFEST_V52.md`. Result:
  future validation operators have exact command order and an interpreter
  precheck; `.venv/bin/python` imports numpy/pandas successfully.
- 2026-07-10T11:06:12Z: Wrote
  `docs/reports/THERAPEUTIC_CLAIM_HIERARCHY_V52.md`. Result: V52 now has an
  explicit hierarchy separating what can be claimed from what is context or a
  future data ask.
- 2026-07-10T11:08:13Z: Wrote
  `docs/validation/TARGET_PACKAGE_ACCEPTANCE_CRITERIA_V52.tsv`. Result:
  incoming monitoring, chr1, postpartum, T/B, and structure-support packages now
  have machine-readable accept/partial/reject criteria.
- 2026-07-10T11:11:25Z: Wrote
  `docs/validation/PROSPECTIVE_MONITORING_UTILITY_STUDY_SKETCH_V52.md`. Result:
  a positive external validation is explicitly separated from clinical utility;
  score-guided action would need a later prospective decision-impact/action
  study, not post-hoc interpretation of Gafson or Karolinska.
- 2026-07-10T11:14:27Z: Wrote
  `docs/validation/MONITORING_CLINICAL_UTILITY_BOUNDARY_CHECKLIST_V52.md`.
  Result: V52 now has explicit allowed/forbidden wording and claim boundaries
  from technical scoreability through treatment-action utility.
- 2026-07-10T11:16:30Z: Wrote
  `docs/workups/genetics/CHR1_COLLABORATOR_ASSAY_REQUEST_APPENDIX_V52.md`.
  Result: chr1 collaborator requests now specify genotype targets, cell-state
  coverage, protein/perturbation expectations, metadata, and package classes
  without reopening chr1 as a target.
- 2026-07-10T11:18:51Z: Wrote
  `docs/reports/THERAPEUTIC_ARTIFACT_MANIFEST_V52.tsv`. Result: V52 artifacts
  now have a machine-readable manifest for downstream navigation and checks.
- 2026-07-10T11:21:43Z: Wrote
  `docs/reports/THERAPEUTIC_ROUTE_RISK_REGISTER_V52.md`. Result: each V52 route
  now has explicit residual risks, mitigation artifacts, and escalation
  triggers, preserving the monitoring-first/no-current-target verdict.
- 2026-07-10T11:23:51Z: Wrote
  `docs/reports/THERAPEUTIC_ROUTE_ASSUMPTION_LEDGER_V52.md`. Result:
  assumptions behind the monitoring-first and no-current-target conclusions are
  explicit, including what future data would revise or falsify them.
- 2026-07-10T11:26:08Z: Wrote
  `docs/validation/INCOMING_PACKAGE_COMMUNICATION_TEMPLATES_V52.md`. Result:
  future package responses can distinguish accepted, partial, rejected, access
  blocked, and missing-field cases without improvising interpretation.
- 2026-07-10T11:28:27Z: Wrote
  `docs/validation/MONITORING_VALIDATION_RESULT_REPORT_TEMPLATE_V52.md`. Result:
  future Gafson/Karolinska output now has a fixed result-report shell with
  preflight, metrics, confounder/batch, class, and non-command sections.
- 2026-07-10T11:30:41Z: Wrote
  `docs/workups/genetics/CHR1_PACKAGE_RESULT_REPORT_TEMPLATE_V52.md`. Result:
  future chr1 packages now have a fixed staged report shell from intake through
  final target-workup-ready, biology-only, wrong-direction, incomplete, or
  closed class.
- 2026-07-10T11:33:05Z: Wrote
  `docs/validation/PACKAGE_CHECKSUM_INTAKE_CHECKLIST_V52.md`. Result: incoming
  monitoring and target packages now have a concise terms, quarantine,
  checksum, raw-git, package-type, and stop/go receipt checklist.
- 2026-07-10T11:35:09Z: Wrote
  `docs/reports/THERAPEUTIC_ROUTE_DECISION_LOG_TEMPLATE_V52.md`. Result:
  future route-status changes now require counted evidence, gate results,
  explicit non-counting context, and consistency checks before commitment.
- 2026-07-10T11:37:24Z: Wrote
  `docs/reports/THERAPEUTIC_ROUTE_STATUS_DASHBOARD_V52.tsv`. Result: operators
  now have a compact machine-readable dashboard of route status, next gate,
  blocker, action, and verdict.
- 2026-07-10T11:39:36Z: Wrote
  `docs/validation/MONITORING_OPERATOR_ONE_PAGE_CARD_V52.md`. Result: future
  monitoring operators have a compact package receipt, command sequence,
  result-class, and non-command quick card.
- 2026-07-10T11:41:35Z: Wrote
  `docs/workups/genetics/CHR1_OPERATOR_ONE_PAGE_CARD_V52.md`. Result: future
  chr1 operators have a compact receipt, staged-review, final-class, and
  non-command quick card.
- 2026-07-10T11:43:58Z: Wrote
  `docs/reports/V52_ARTIFACT_CROSS_LINK_AUDIT.md`. Result: key V52 artifacts
  are discoverable from manifest, index, status, next actions, and queue; the
  only summary-card exception is the intentional absence of a self-reference.
- 2026-07-10T11:47:20Z: Wrote
  `docs/workups/genetics/OPENGWAS_PRE_EXPIRY_BOUNDED_POLISH_COMMANDS_V52.md`.
  Result: renewed-token use before `2026-07-24 08:00 UTC` is limited to the
  auth sentinel, V14 confirmed-locus rerun, and V19 chr1 local reanalysis;
  older exploratory scripts are explicitly not pre-approved for V52 polish.
- 2026-07-10T11:51:34Z: Rebuilt the local sparse TF-IDF knowledge index with
  `.venv_v3_py312/bin/python scripts/build_knowledge_index.py`. Result:
  `knowledge/.index/manifest.json` reports `783` documents; smoke query
  `V52 therapeutic path monitoring chr1 OpenGWAS` returned V52 therapeutic
  artifacts including `docs/reports/THERAPEUTIC_PATH_V52.md` and
  `docs/workups/genetics/OPENGWAS_PRE_EXPIRY_BOUNDED_POLISH_COMMANDS_V52.md`.
- 2026-07-10T11:54:01Z: Wrote
  `docs/validation/VALIDATION_PACKAGE_FIELD_DICTIONARY_V52.tsv`. Result:
  monitoring, chr1, postpartum, T/B, pharmacodynamic-only, and structure-context
  packages now have a field-level required/optional dictionary aligned to the
  existing acceptance criteria and request packet.
- 2026-07-10T11:57:15Z: Wrote
  `docs/reports/THERAPEUTIC_REVIEWER_QUICKSTART_V52.md`. Result: external
  reviewers now have a reading order, role-specific artifact map, and challenge
  checklist that keeps monitoring validation, target handoff, structure context,
  and future data asks separate.
- 2026-07-10T12:00:31Z: Wrote
  `docs/validation/MONITORING_PUBLIC_WORDING_TABLE_V52.tsv`. Result: each
  future monitoring result class now has pre-specified public wording, internal
  wording, required caveat, forbidden wording, and next action.
- 2026-07-10T12:04:38Z: Wrote
  `docs/workups/genetics/CHR1_NO_GO_COMMUNICATION_APPENDIX_V52.md`. Result:
  chr1 now has collaborator-safe language that preserves the real-biology
  handoff while explicitly blocking GPR25/KIF21B target promotion without
  genotype-linked cell-state, direction, perturbation, and modality evidence.
- 2026-07-10T12:08:26Z: Wrote
  `docs/reports/V52_OPERATOR_ARTIFACT_HASH_SNAPSHOT.tsv`. Result: key
  monitoring, chr1, and OpenGWAS operator artifacts now have SHA256 hashes for
  future package-handoff drift checks; mutable navigation docs are excluded.
- 2026-07-10T12:11:42Z: Refilled the V52 backlog and wrote
  `docs/validation/MONITORING_RESULT_CLASS_EXAMPLES_V52.md`. Result: future
  monitoring package outcomes now have concrete examples mapping common
  scenarios to the conservative V42/V52 result classes.
- 2026-07-10T12:14:04Z: Wrote
  `docs/workups/genetics/CHR1_WRONG_DIRECTION_CONTROL_CHECKLIST_V52.md`.
  Result: future chr1 perturbation packages now have pre-specified labels and
  interpretation rules so inhibitors, knockdowns, antagonists, and other
  wrong-direction tests remain controls unless genetics proves them protective.
- 2026-07-10T12:16:32Z: Wrote
  `docs/reports/POST_VALIDATION_ROUTE_UPDATE_PLAYBOOK_V52.md`. Result:
  future monitoring and chr1 package outcomes now have explicit route-status
  transition rules and required downstream artifact updates.
- 2026-07-10T12:19:05Z: Wrote
  `docs/reports/THERAPEUTIC_NO_TARGET_PUBLIC_ABSTRACT_V52.md`. Result:
  external/public wording now states the no-current-target conclusion while
  preserving the monitoring validation path as the live actionable route.
- 2026-07-10T12:21:21Z: Wrote `meta/OPENGWAS_EXPIRY_DAY_RUNBOOK_V52.md`.
  Result: future sessions now have explicit expiry-day, expired-token, service
  blocker, and renewed-token routing that prevents OpenGWAS auth failures from
  being interpreted as genetics nulls.
- 2026-07-10T12:23:48Z: Resume checkpoint after context compaction. Continuing
  the same open V52 active interval with the expiry-day runbook guard,
  commit, and push step before starting the hash-verification command note.
- 2026-07-10T12:29:02Z: Wrote
  `docs/reports/V52_OPERATOR_ARTIFACT_HASH_VERIFY_COMMANDS.md`. Result: V52
  operator handoff artifacts now have an explicit SHA256 drift-check command,
  mismatch interpretation table, and regeneration rule.
- 2026-07-10T12:36:11Z: Wrote
  `docs/validation/VALIDATION_PACKAGE_ROUTE_CLASSIFIER_V52.tsv` and refilled
  the backlog above threshold. Result: incoming packages now route mechanically
  to monitoring validation, chr1 target-resolution, secondary biology,
  context-only, access-blocked, or unscoreable classes before analysis.
- 2026-07-10T12:41:22Z: Wrote
  `docs/validation/VALIDATION_PACKAGE_ROUTE_CLASSIFIER_EXAMPLES_V52.tsv`.
  Result: ten plausible incoming package shapes now have pre-analysis route
  classes, allowed interpretations, forbidden interpretations, and next
  actions.
